Intervention Review

Corticosteroids for Guillain-Barré syndrome

  1. Richard AC Hughes1,*,
  2. Anthony V Swan2,
  3. Pieter A van Doorn3

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 17 FEB 2010

Assessed as up-to-date: 7 JUN 2009

DOI: 10.1002/14651858.CD001446.pub3

How to Cite

Hughes RAC, Swan AV, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database of Systematic Reviews 2010, Issue 2. Art. No.: CD001446. DOI: 10.1002/14651858.CD001446.pub3.

Author Information

  1. 1

    National Hospital for Neurology and Neurosurgery, MRC Centre for Neuromuscular Disease, London, UK

  2. 2

    National Hospital for Neurology and Neurosurgery, Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, London, UK

  3. 3

    Erasmus Medical Center, Department of Neurology, Rotterdam, Netherlands

*Richard AC Hughes, MRC Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, PO Box 114, Queen Square, London, WC1N 3BG, UK. r.hughes@ion.ucl.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 17 FEB 2010

SEARCH

  1. Current Version

    Corticosteroids for Guillain-Barré syndrome

    Richard AC Hughes, Anthony V Swan and Pieter A van Doorn

    Article first published online: 17 FEB 2010 | DOI: 10.1002/14651858.CD001446.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Corticosteroids for Guillain-Barré syndrome

    Richard AC Hughes, Anthony V Swan, Rinske van Koningsveld and Pieter A van Doorn

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD001446.pub2

  2. Version 1

    Corticosteroids for Guillain-Barré syndrome

    RAC Hughes and FGA van der Meché

    Article first published online: 25 JAN 2006 | DOI: 10.1002/14651858.CD001446